Emerging topics and practical aspects for an appropriate use of amyloid PET in the current italian context(51 visite) Nobili F, Cagnin A, Calcagni ML, Chincarini A, Guerra UP, Morbelli S, Padovani A, Paghera B, Pappata S, Parnetti L, Sestini S, Schillaci O
Impact factor: 2.481, Impact factor a 5 anni: 1.952
Url: Non disponibile.
Parole chiave: Amyloid Metabolism
, Image Processing, Computer-Assisted
, Positron-Emission Tomography Statistics, Numerical Data
, Radioactive Tracers
*** IBB - CNR *** Department of Neuroscience (DINOGMI), University of Genoa, Neurology Clinic, Polyclinic San Martino Hospital, Genoa, Italy - firstname.lastname@example.org. San Camillo Hospital IRCCS, Venice, Italy. Institute of Nuclear Medicine, Universita Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy. National Institute for Nuclear Physics (INFN), Genoa section, Genoa, Italy. Nuclear Medicine Unit, Poliambulanza Fundation, Brescia, Italy. Department of Health Sciences (DISSAL), University of Genoa, Nuclear Medicine Unit, Polyclinic San Martino Hospital, Genoa, Italy. Department of Clinical and Experimental Sciences, University of Brescia, Neurology Clinic, Spedali Civili, Brescia, Italy. Institute of Biostructure and Bioimaging, National Research Council, Naples, Italy. Center for Memory Disorders and Laboratory of Clinical Neurochemistry, Neurology Clinic, University of Perugia, Perugia, Italy. Department of Diagnostic Imaging, Nuclear Medicine Unit, N.O.P., S. Stefano, U.S.L. Toscana Centro, Prato, Italy. Department of Biomedicine and Prevention, University of Rome Tor Vergata and IRCCS Neuromed, Rome, Italy. San Camillo IRCCS Hospital, Venice, Italy. Unit of Nuclear Medicine, Poliambulanza Fundation, Brescia, Italy.
In May, 2017 some representatives of the Italian nuclear medicine and <br>neurological communities spontaneously met to discuss the issues emerged<br> during the first two years of routine application of amyloid PET with <br>fluorinated radiopharmaceuticals in the real world. The limitations of a<br> binary classification of scans, the possibility to obtain early images <br>as a surrogate marker of regional cerebral bloos flow, the need for <br>(semi-)quantification and, thus, the opportunity of ranking brain <br>amyloidosis, the correlation with Aβ42 levels in the cerebrospinal <br>fluid, the occurrence and biological meaning of uncertain/boderline <br>scans, the issue of incidental amyloidosis, the technical pittfalls <br>leading to false negative/positive results, the position of the tool in <br>the diagnostic flow- chart in the national reality, are the main topics <br>that have been discussed. Also, a card to justify the examination to be <br>filled by the dementia specialist and a card for the nuclear medicine <br>physician to report the exam in detail have been approved and are <br>available in the web, which should facilitate the creation of a national<br> register, as previewed by the 2015 intersocietal recommendation on the <br>use of amyloid PET in Italy. The content of this discussion could <br>stimulate both public institutions and companies to support further <br>research on these topics.
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(305 visite) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 DettagliEsporta in BibTeXEsporta in EndNote
63 Records (60 escludendo Abstract e Conferenze). Impact factor totale: 209.072 (203.777 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 245.925 (239.18 escludendo Abstract e Conferenze).